|
|
|
|
LEADER |
02199 am a22002293u 4500 |
001 |
125924 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Brown, Breann L.
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biology
|e contributor
|
700 |
1 |
0 |
|a Kardon, Julia R.
|e author
|
700 |
1 |
0 |
|a Sauer, Robert T
|e author
|
700 |
1 |
0 |
|a Baker, Tania
|e author
|
245 |
0 |
0 |
|a Structure of the Mitochondrial Aminolevulinic Acid Synthase, a Key Heme Biosynthetic Enzyme
|
260 |
|
|
|b Elsevier BV,
|c 2020-06-22T20:21:20Z.
|
856 |
|
|
|z Get fulltext
|u https://hdl.handle.net/1721.1/125924
|
520 |
|
|
|a 5-Aminolevulinic acid synthase (ALAS) catalyzes the first step in heme biosynthesis. We present the crystal structure of a eukaryotic ALAS from Saccharomyces cerevisiae. In this homodimeric structure, one ALAS subunit contains covalently bound cofactor, pyridoxal 5'-phosphate (PLP), whereas the second is PLP free. Comparison between the subunits reveals PLP-coupled reordering of the active site and of additional regions to achieve the active conformation of the enzyme. The eukaryotic C-terminal extension, a region altered in multiple human disease alleles, wraps around the dimer and contacts active-site-proximal residues. Mutational analysis demonstrates that this C-terminal region that engages the active site is important for ALAS activity. Our discovery of structural elements that change conformation upon PLP binding and of direct contact between the C-terminal extension and the active site thus provides a structural basis for investigation of disruptions in the first step of heme biosynthesis and resulting human disorders. Brown et al. determine structures of ALAS, a heme biosynthetic enzyme, that reveal how its PLP cofactor orders the active site. These structures also reveal the positioning of the eukaryote-specific C-terminal extension, providing a framework for understanding the mechanism of erythroid disease-causing mutations.
|
520 |
|
|
|a Burroughs Wellcome Postdoctoral Enrichment Program (Award 1015092)
|
520 |
|
|
|a National Institutes of Health (Award F32DK095726)
|
520 |
|
|
|a National Institutes of Health (Grant R01 DK115558)
|
546 |
|
|
|a en
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Structure
|